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http:WHAT THIS PAPER ADDS
Proximal neck angulation is a risk factor for adverse events following endovascular aneurysm repair (EVAR). The
ﬁrst study to assess mid-term outcomes and morphology changes in the proximal neck in patients with severely
angulated proximal neck treated with a late-generation endograft is presented. This study shows that clinical
outcome following EVAR in patients with severe proximal neck angulation is not signiﬁcantly different from
those patients with more favorable proximal anatomy.Objective: To determine if mid-term outcome following endovascular aneurysm repair (EVAR) with the Endurant
Stent Graft (Medtronic, Santa Rosa, CA, USA) is inﬂuenced by severe proximal neck angulation.
Methods: A retrospective caseecontrol study was performed using data from a prospective multicenter
database. All measurements were obtained using dedicated reconstruction software and center-lumen line
reconstruction. Patients with neck length >15 mm, infrarenal angle (b) >75, and/or suprarenal angle (a) >60,
or neck length >10 mm with b >60, and/or a >45 were compared with a matched control group. Primary
endpoint was primary clinical success. Secondary endpoints were freedom from rupture, type 1A endoleak, stent
fractures, freedom from neck-related reinterventions, and aneurysm-related adverse events. Morphological neck
variation over time was also assessed.
Results: Forty-ﬁve patients were included in the study group and were compared with a matched control group
with 65 patients. Median follow-up time was 49.5 months (range 30.5e58.4). The 4-year primary clinical success
estimates were 83% and 80% for the angulated and nonangulated groups (p ¼ .42). Proximal neck angulation did
not affect primary clinical success in a multivariate model (hazard ratio 1.56, 95% conﬁdence interval 0.55e4.41).
Groups did not differ signiﬁcantly in regard to freedom from rupture (p ¼ .79), freedom from type 1A endoleak
(p ¼ .79), freedom from neck-related adverse events (p ¼ .68), and neck-related reinterventions (p ¼ .68). Neck
angle reduction was more pronounced in patients with severe proximal neck angulation (mean Da 15.6, mean
Db 30.6) than in the control group (mean Da 0.39, mean Db 5.9) (p < .001).
Conclusion: Mid-term outcomes following EVAR with the Endurant Stent Graft were not inﬂuenced by severe
proximal neck angulation in our population. Despite the conformability of the device, moderate aortic neck
remodeling was identiﬁed in the group of patients with angulated neck anatomy on the ﬁrst computed
tomography scan after implantation with no important further remodeling afterwards. No device integrity
failures were encountered.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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//dx.doi.org/10.1016/j.ejvs.2014.10.001complications and have restricted suitability for endovas-
cular aneurysm repair (EVAR).1 Owing to an expected in-
crease of risk following EVAR in the presence of very
angulated necks, different thresholds of proximal neck
angulation have been set by each manufacturer’s in-
structions for use (IFUs), reﬂecting the different extent to
which each endograft is expected to perform in these
challenging anatomies.
The Endurant Stent Graft (Medtronic, Santa Rosa, CA,
USA) is a late-generation endograft that has been
20 N.F.G. Oliveira et al.speciﬁcally designed to treat more challenging anatomy by
increasing conformability, proximal seal, and ﬁxation,
allowing the treatment of a broadened group of patients.2
Some data suggest that these features are well suited for
the treatment of severely angulated proximal anatomy,3 but
long-term data are lacking.
The hypothesis of this study is that severe proximal neck
angulation has no inﬂuence on mid-term outcome after
EVAR with the use of the Endurant Stent Graft System.
METHODS
One hundred and ten patients who were included in a
previously published caseecontrol study that reported on
30-day outcomes after EVAR with the Endurant Stent Graft
in severely angulated proximal aneurysm necks were
reviewed.4 This study was based on a prospectively main-
tained database from three high-volume centers in the
Netherlands (St. Antonius Hospital, Nieuwegein, University
Medical Center, and Utrecht and Erasmus University Med-
ical Center). This study complied with the principles of the
Declaration of Helsinki. Informed consent was not required
according to institutional policy on retrospective research.Patient population
Study design and patient selection have been reported
previously, in detail.4 In summary, in the period 2008e09,
418 patients with abdominal aortic aneurysms (AAAs) were
treated in the three centers. Of these, 271 patients elec-
tively received an Endurant Stent Graft for a degenerative
AAA. Patients with mycotic aneurysms or prior aortic
reconstructive surgery were excluded. The treatment deci-
sion and type of repair offered were individualized ac-
cording to anatomical determinants, health status, and
history of previous abdominal surgery (hostile abdomen).
Patient preference was also taken into account before
obtaining informed consent. All patients with severely
angulated proximal anatomy selected for endovascular
repair were treated consecutively solely with an endurant
bifurcated endograft.
Angulation measurement has been reported previously.4
Brieﬂy, following three-dimensional image reconstruction,
the aorta is turned 360 perpendicularly to the center
lumen line (CLL) ﬂexure, and then rotated along its longi-
tudinal axis until the sharpest angle is found. The alpha
angle is formed between the suprarenal aorta and the
aneurysm neck, and the beta angle between the aneurysm
neck and sac. Angulation inclusion criteria were deﬁned
according to the maximum proximal neck angulation
described in Medtronics’ IFUs for the Endurant Stent Graft.5
Accordingly, patients were included in the angulated group
if one of the following two combinations occurred: a neck
length >15 mm with an infrarenal angle (b) >75, and/or
suprarenal angle (a) >60, or neck length >10 mm with b
>60 and/or a >45. Forty-ﬁve (16.5%) of the patients
electively receiving an Endurant Stent Graft were included
in the angulated group and thus treated outside the de-
vice’s IFUs. Twenty-three (51.1% of the angulated group)patients were included owing to b angulation, 14 (31.1%)
owing to both a and b angulation, and eight (17.8%) owing
solely to a angulation. A control group matched for baseline
clinical characteristics of 65 patients was selected from the
remaining elective infrarenal EVAR patients from the same
hospitals in the same time period using the same Endurant
endograft.4
Postoperative surveillance
Follow-up protocols consisted of a contrast-enhanced
computerized tomography angiography (CTA) at 1 and 12
months, and annually thereafter. According to the treating
physician’s expectation, in selected patients with expected
lower risk of complications or renal function impairment,
CTA was replaced by colored-duplex ultrasound or by
noncontrasted CT.
Data management
Baseline clinical, anatomic, and intraoperative data were
acquired at the time of surgery. All subsequent long-term
follow-up data were prospectively obtained upon outpa-
tient clinical visits.
Image analysis and measurements
All measurements (diameters, length, and volume) were
performed using semiautomatically generated CLL recon-
struction on a workstation with dedicated reconstruction
software (3Mensio Vascular 4.2; Medical Imaging B.V.,
Bilthoven, the Netherlands). All long-term imaging data
were obtained by a single observer with experience in im-
age analysis (N.F.G.O.). In previous reports, our group
demonstrated high rates of interobserver agreement in
respect to aneurysm diameter, neck diameter, neck length,
and proximal seal length measurements,6e8 obtained ac-
cording to this methodology. Aneurysm volume was
measured according to previously validated methodology.7
Angulation measurements were executed in a standard-
ized and previously validated method.9
Deﬁnitions
Reporting was performed according to the guidelines from
the Society for Vascular Surgery/American Association of
Vascular Surgery ad hoc Committee for Standardized
Reporting Practices in Vascular Surgery.10 Clinical success,
primary clinical success, primary assisted clinical success,
and secondary clinical success were deﬁned accordingly.10
Oversizing was determined by dividing the difference be-
tween the implanted main body diameter and the reference
neck diameter in the ﬁrst 15 mm of the infrarenal neck by
the latter. Proximal seal length was deﬁned as the extension
of complete circumferential apposition between the
endograft and the aortic wall, and was determined ac-
cording to a previously published method.8 The length of
the neck was deﬁned as the distance between the most
distal point of the origin of the lowermost renal artery and
the beginning of the aneurysm. For proximal seal
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were placed from the origin of superior mesenteric artery
and at every 2 mm, and progressed caudally until reaching
the ﬂow divider. Distance from the lowermost renal artery
to the endograft was measured on CLL reconstruction as
the distance between a tangent horizontal plan passing
through the most distal point of the circumference of the
lowermost renal artery ostium and the ﬁrst covered stent of
the endograft on last imaging available. Migration was
deﬁned by subtracting the distance from the lowermost
renal artery to endograft measured on ﬁrst postoperative
imaging from last available imaging exam.
Sac growth was deﬁned as a >5% increase in aneurysm
sac volume or as a >5 mm increase in sac diameter.10 Long-
term sac dynamics were deﬁned as the difference in
maximum diameter between the ﬁrst (within 30 days) and
the last postoperative imaging examinations. Barb detach-
ment was deﬁned on CLL reconstruction as nonapposition
of a proximal uncovered stent barb to the aortic wall and
distance of detachment was measured between the outer
surface of the barb and the inner limit of the aortic wall.
Posterior neck bulging was deﬁned by the increase of neck
diameter in quadrant deﬁned by the convexity of the su-
prarenal angle, despite maintenance of adequate endograft
apposition to the aortic wall in the remaining quadrants on
surveillance imaging.
AAA-related adverse events were deﬁned as a composite
of the following: direct (type 1 or 3) or undetermined type
endoleaks, aneurysm sac growth, migration >10 mm, de-
vice integrity failure, AAA-related death, late post-
implantation AAA rupture, or any AAA-related secondary
intervention. Undetermined endoleak was considered if
contrast was identiﬁed within the aneurysm sac but outside
the endograft and if its origin could not be imputed to
failure of proximal or distal seal or patent aortic branch
vessels. Secondary interventions were considered if per-
formed to resolve or prevent a possible complication, and
included endovascular procedures (proximal cuff and stent
implant, distal extension implant, catheter-based throm-
bolysis, iliac angioplasty, coil or glue embolization of aortic
branch vessels), as well as surgical procedures (balloon
thrombectomy, femoro-femoral crossover, conversion to
open repair, open or laparoscopic ligation of collaterals).Endpoints
The primary study endpoint was primary clinical success.
Secondary endpoints were freedom from rupture, freedom
from type 1A endoleak, freedom from neck-related rein-
terventions and aneurysm-related adverse events. Addi-
tional individual elements of the latter composite
endpointdaneurysm expansion (diameter 5 mm, volume
5%), type 1 B and type 3 endoleaks, graft or limb
thrombosis, graft infection, conversion to open repair or
death as a result of aneurysm-rupture or aneurysm-related
treatmentdwere also explored separately. Variation of
neck-related morphological features and device-related
outcomes in the proximal neck were also assessed.Statistical analysis
Categorical variables are presented as count and percent-
age, and were compared using the Pearson’s chi-square
test. Continuous variables are presented as mean, SD, me-
dian, interquartile range (IQR), and range. Differences be-
tween groups were analyzed using the ManneWhitney U
test for independent samples with non-normal distribu-
tions, with the Student t test and signiﬁcance with the in-
dependent samples test for nonrelated variables with
normal distributions, and the paired Student t test for
paired variables. Survival curves for primary clinical success
and freedom from neck-related reinterventions were esti-
mated by KaplaneMeier methods, and equality was eval-
uated with the ManteleCox log-rank test. Long-term
outcome variables were assessed by Cox hazards regression
models. Multivariate regression was performed to include
the most signiﬁcant morphologic features determined by
previous univariate analysis (neck diameter and neck
length). Conﬁdence intervals (CIs) of 95% were used and
statistical signiﬁcance was considered if p < .05. All statis-
tical analysis was performed using SPSS 21.0 (IBM, Armonk,
NY, USA).RESULTS
Clinical and anatomical baseline characteristics are pre-
sented in Table 1. At the time of surgery, the mean age of
the patients was 73.9  7.9 years, and 86.4% were men.
Both groups were not signiﬁcantly different regarding
comorbidities. Anatomic characterization has been
exhaustively described elsewhere.4 Mean a angles were
51.4  21.1 and 17.9  17.0, and mean b angles were
80.8  15.6 and 35.4  20.0 for the angulated and control
groups, respectively. Intraobserver variability for neck
angulation measurements was tested for a sample of 44
patients, with very good agreement (Pearson’s correlation
coefﬁcient, a angle 0.965, p < .01; b angle 0.932,
p < .01), and BlandeAltman plots were created (Fig. 1).
Patients in the angulated group presented signiﬁcantly
larger aneurysms, with a mean aneurysm volume of
309.5  30.1 cc (p < .001) and shorter proximal neck
lengths (mean 27.2 mm  14.8; p < .01). Procedural-
related and early outcomes have been previously reported.4
Median follow-up time was 49.5 months (IQR 30.5e58.4;
range 0.43e67.1 months). Follow-up time differed between
groups, with median of 45.3 months (range 1.5e61.6
months) for the angulated group and a median of 52.1
months (range 0.4e67.1 months) for the nonangulated
group (p ¼ .03).
Early postoperative mortality occurred in one patient in
the study group and two patients in the control group as
previously reported.4 Of the remaining 107 patients, post-
operative CTAs were available for 44 (98.0%) patients of the
angulated group and 62 (95.0%) patients in the control
group. Only one patient did not undergo postoperative CTA
owing to impaired renal function and an uneventful follow-
up. A 1-year CTA was obtained for 91, a 2-year CTA for 77, a
3-year CTA for 52, and a 4-year CTA for 36 patients.
Figure 1. BlandeAltman plots showing intraobserver variability for
suprarenal (top) and infrarenal (bottom) neck angulation on last
imaging available in a group of 44 patients.
Table 1. Baseline clinical and anatomic characteristics.
Characteristic Angulated
(n ¼ 45)
Nonangulated
(n ¼ 65)
p
Age (y), mean (SD) 75.6 (6.5) 72.7 (8.5) .49
Male 36 (80.0) 59 (90.8) .11
Smoking 32 (71.1) 51 (78.5) .38
Hypertension 25 (55.6) 35 (53.8) .70
Cardiac disease 22 (48.9) 27 (41.5) .45
Diabetes 6 (13.3) 15 (23.1) .20
COPD 14 (31.1) 13 (20.0) .18
Creatinine clearance
<60 mL/min/1.73 m2
16 (35.6) 20 (30.8) .60
Cerebrovascular disease 4 (8.9) 12 (18.5) .16
Peripheral arterial disease 11 (24.4) 15 (23.1) .87
ASA class III/IV 33 (73.3) 43 (66.2) .42
AAA Ø (mm), mean (SD) 68.6 (14.2) 58.8 (7.6) <.01
AAA volume (cc),
mean (SD)
309.5 (30.1) 187.4 (8.2) <.01
Proximal neck Ø (mm),
mean (SD)
25.2 (4.2) 25.5 (4.5) .71
Proximal neck length (mm),
mean (SD)
27.2 (14.8) 32.6 (13.1) .05
Neck thrombus >25% of
circumference
8 (17.8) 10 (15.4) .74
Neck calciﬁcation >25% of
circumference
3 (6.7) 1 (1.5) .16
a Angle (degrees),
mean (SD)
51.4 (21.1) 17.9 (17.0) <.01
b Angle (degrees),
mean (SD)
80.8 (15.6) 35.4 (20.0) <.01
Note. Values given as n (%) unless otherwise indicated.
COPD ¼ chronic obstructive pulmonary disease;
ASA ¼ American Society of Anesthesiologists; AAA ¼ abdominal
aortic aneurysm.
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Primary clinical success was obtained in 86 (78.2%) patients.
Forty of these patients had angulated proximal anatomy
(88.9%) and 46 had less challenging necks (70.8%) (p ¼ .02).
KaplaneMeier survival estimates for primary clinical success
were not different for patients with or without proximal
angulated anatomy (p ¼ .42; Fig. 2A). The 2- and 4-year
estimates for primary success rates were 93% and 83%
for the angulated group, 92% and 80% for the control
group. On multivariate regression analysis, patients with
severe proximal neck angulation were not at increased risk
of presenting worse primary clinical success compared with
the control group (Hazard ratio [HR] 1.56, 95% CI 0.55e
4.41; p ¼ .40). Overall primary-assisted and secondary
clinical success were not different among both groups
(Table 2).
Freedom from late aneurysm rupture
Late aneurysm rupture occurred in three (2.7%) patients,
one in the angulated group (2.2%) and two in the non-
angulated group (3.1%) (p ¼ .79) and resulted in the death
of one patient in each group (1.8%) (p ¼ .79; Table 3). In
the nonangulated group, one patient developed an infec-
tion of the endograft with subsequent type 1a endoleak andaneurysm rupture. Despite undergoing a proximal cuff
insertion, this patient died 26 days after reintervention. The
other patient from the nonangulated group presented a
type 1b endoleak with rupture, which was successfully
treated with a limb extension. In the angulated group, one
patient presented with aneurysm rupture due to a type 1b
endoleak.Freedom from proximal type 1 endoleaks and neck-related
reinterventions
Secondary interventions due to neck-related adverse events
occurred in three patients. In the angulated group, one
patient who had received a limb relining owing to a type 3
endoleak became symptomatic 5 months later, without
Figure 2. (A) KaplaneMeier analysis of long-term primary clinical success. (B) KaplaneMeier analysis of freedom from neck-related
reinterventions. Note. EVAR ¼ endovascular aneurysm repair.
Mid-Term Results of EVAR 23rupture, and was converted to open repair. Intraoperatively
a position-dependent type 1a endoleak reported. In the
nonangulated group, two patients required proximal cuffs:
one patient who developed an endograft infection and
consequent proximal type 1 endoleak, as reported above;
the other patient was treated for a secondary type 1a
endoleak with a proximal cuff but required also a proximal
Palmaz stent 1 year later owing to progressive neck dilata-
tion and endoleak relapse. No differences between Kaplane
Meier survival curves were demonstrated for proximal neck-
related reintervention (p ¼ .68) (Fig. 2B). The 2- and 4-year
estimates for freedom from neck-related reinterventions
were 98% and 95% in the angulated group, while in the
control group they were both 97%. In addition to these
three patients listed, one further patient with severe
proximal neck angulation developed a proximal type 1
endoleak but died before receiving treatment for theTable 2. Long-term clinical outcomes.
Angulated
(n ¼ 45)
Nonangulated
(n ¼ 65)
p
Primary clinical success 40 (88.9) 46 (70.8) .02
Assisted primary
clinical success
42 (93.3) 60 (92.3) .84
Secondary clinical
success
43 (95.6) 63 (96.9) .71
Late aneurysm-related
mortality
1 (2.2) 1 (1.5) .79
All-cause mortality 11 (24.4) 11 (16.9) .33
Note. Values given as n (%).endoleak owing to unrelated medical complications
following refractory lower intestinal bleeding. Patients in
the angulated group did not present more proximal type 1
endoleaks when compared with the control group (p ¼ .79).AAA-related adverse events
During the follow-up period, aneurysm-related adverse
events were registered in 23 (20.9%) patients, six (13.3%) of
whom had severely angulated necks; the remaining 17 did
not (26.2% of the control group) (p ¼ .10; Table 3). Patients
with severe proximal angulation were not at increased risk
for adverse events (HR ¼ 1.65, 95% CI 0.57e4.75; p ¼ .35).
Patients in the angulated group underwent less second-
ary interventions than in the control group (p ¼ .04). On
multivariate analysis, an increased risk of having a second-
ary intervention could not be identiﬁed among the study
group (HR ¼ 1.19, 95% CI 0.35e4.02; p ¼ .78).
Sac growth >5 mm did not occur in the angulated group
but was identiﬁed in six (9.7%) patients in the nonangulated
group (p ¼ .03). Type 2 endoleak was considered the cause
of sac growth in three patients; two of these patients un-
derwent glue/coil embolization, which did not prevent
progressive sac growth. The remaining cases of sac growth
occurred in the presence of direct endoleaks.Device-related outcomes in the proximal neck
Postoperative CTAs were available for 44 (98.0%) patients in
the angulated group and 62 (95.0%) patients in the control
group.
Table 3. Abdominal aortic aneurysm (AAA)-related events.
Angulated
(n ¼ 45)
Nonangulated
(n ¼ 65)
p
AAA-related adverse
events, patients
6 (13.3) 17 (26.2) .10
Aneurysm rupture 1 (2.2) 2 (3.1) .79
Late aneurysm-related
mortality
1 (2.2) 1 (1.5) .79
Secondary endoleaks
Type 1adpatients
Type 1adevents
2 (4.4)
2
2 (3.1)
3
0.79
Type 1b 2 8
Type 2 3 7
Type 3 1 0
Sac growth 0 (0) 6 (9.7) .03
Sac shrinkage 10 mm 17 (38.6) 22 (35.5) .74
Graft infection 0 1
Limb thrombosis, events 1 7
Endograft occlusion 1 0
Buttocks claudication 0 1a
Access artery thrombosis 1a 0
Migration 0 0
Device failure 0 0
Secondary interventionsd
patients
Secondary interventionsd
events
4 (8.9)
5
16 (24.6)
22
.04
Proximal stent/cuff 0 3
Limb extension 2 9
Coil/glue embolization 0 4
Relining 0 0
Conversion to open repair 1 0
Conversion to aortouniiliac 0 0
Open/laparoscopic
fenestration
0 0
Thrombolysis and iliac PTA 2 4
Isolated iliac PTA 0 2
Note. Values given as n (%). PTA ¼ percutaneous transluminal
angioplasty.
a No intervention took place in these patients.
24 N.F.G. Oliveira et al.Mean distance from the lowermost renal artery was not
signiﬁcantly increased in patients with angulated anatomy
(4.9  3.9 mm) when compared with the patients without
severe proximal angulation (3.9  3.5 mm) (p ¼ .15) on lastTable 4. Long-term morphologic and device-related outcomes in the p
Angu
Migration distance (mm), mean (SD) 1.9
Proximal seal length on last imaging (mm), mean
(SD)
16.7
a Angle on last imaging (degrees), mean (SD) 35.5
b Angle on last imaging (degrees), mean (SD) 50.4
Da Angle compared with 30-d CTA (degrees),
mean (SD)
1.1
Db angle compared with 30-d CTA (degrees),
mean (SD)
1.0
Neck dilatation compared with baseline (mm),
mean (SD)
3.0
Note. CTA ¼ computerized tomographic angiography.CTA. Mean endograft migration distance measured be-
tween the ﬁrst and the last postoperative imaging available
did not differ signiﬁcantly among groups (Table 4).
Mean proximal seal length was signiﬁcantly shorter for
the angulated group (16.7 mm) in comparison with the
nonangulated patients (23.7 mm) (p < .01) on last imaging
available. Moreover, patients with severe proximal neck
angulation were at higher risk of presenting short
(<10 mm) proximal seal lengths (HR 4.91, 95% CI 1.58e
15.31; p < .01). However, signiﬁcant differences were
already present on the ﬁrst postoperative CT, where mean
proximal seal length was 16.8  8.5 mm in the angulated
group and 22.1  8.8 mm in patients without proximal
neck angulation (p ¼ .01) and were not dissimilar from the
proximal seal lengths measured on the last imaging for
both angulated (p ¼ .18) of nonangulated (p ¼ .36)
groups.
Stent fracture was not identiﬁed among any of the
groups. Barb detachment was encountered in 13 (11.8%)
patients: eight (17.8%) in the study group and ﬁve (7.8%) in
the control group, which was not signiﬁcantly different
(p ¼ .12). Mean distance from wall to barb was also not
signiﬁcantly different among groups (angulated patients:
3.6  2.2 mm; controls 2.2  0.65 mm [p ¼ .13]). On
multivariate regression, patients with very angulated prox-
imal neck anatomy were found to be at a higher risk of
presenting barb detachment (HR 3.59, 95% CI 1.14e11.33;
p ¼ .03). Multiple barb detachment was not identiﬁed in
our population.
Proximal neck morphological outcomes
Suprarenal and infrarenal angles remained signiﬁcantly
different between the two groups (p < .01) after EVAR.
Angle reduction was signiﬁcantly more pronounced in pa-
tients with severe proximal neck angulation when
compared with the control group (Table 4). However, when
comparing the last available CTA with the ﬁrst post-
operative one, the suprarenal and infrarenal angles did not
change signiﬁcantly in either angulated or nonangulated
neck patients (Fig. 3).
Mean baseline neck diameter was 25.2  4.2 mm in the
severe neck angulation group and 25.5  4.5 mm in theroximal neck.
lated (n ¼ 44) Nonangulated
(n ¼ 62)
p
(2.6) 1.1 (1.6) .22
(9.3) 23.7 (10.9) <.01
(17.6) 16.7 (12.1) <.01
(19.4) 29.8 (16.7) <.01
(11.9) 1.6 (10.8) .81
(21.0) 4.3 (15.9) .14
(2.0e5.0) 4.0 (1.0e5.3) .55
Figure 3. Evolution of proximal aneurysm neck angulation following endovascular aneurysm repair with the Endurant Stent Graft (left,
baseline, middle 30-d imaging; right, 4-year follow-up).
Mid-Term Results of EVAR 25control group. Patients with angulated proximal necks had
shorter neck lengths (27.2  14.8 mm) when compared
with the control group (32.6  13.1 mm) (p ¼ .05). Mean
neck dilatation was 12.6  12.5% and 13.8  10.7% when
compared with baseline diameters among patients with and
without severe proximal neck angulation, respectively, and
did not differ signiﬁcantly (p ¼ .59). Mean device oversizing
was 21.4  10.2% in the angulated group and 16.1  9.4%
in the control group (p ¼ .01). Posterior bulging occurred in
three patients (6.8%) in the angulated group and in one
patient (2.2%) without angulated anatomy, which was not
signiﬁcantly different between both groups (p ¼ .17).
However, in one of the patients in the angulated group it
was associated with a proximal type 1 endoleak but no
intervention took place as this patient died in the sequence
of lower intestinal bleeding, as reported above.
DISCUSSION
The present study is the ﬁrst to evaluate mid-term outcome
and morphology changes of patients with severely angu-
lated proximal neck treated with a late-generation endog-
raft. Despite concerns over implantation accuracy and
durability after EVAR in angulated proximal aneurysm
necks, our results suggest that EVAR with the Endurant
Stent Graft in adequately selected patients with severe
proximal neck angulation results in acceptable mid-term
outcomes. In our study, secondary interventions were un-
expectedly more frequent in the control group and were
mostly performed owing to complications unrelated to the
proximal neck (distal type 1 endoleaks, type 2 endoleaks,
limb occlusion).
Altered blood ﬂow patterns due to severe angulation
proximal neck angulation have been found to increased
drag forces on endografts, increasing the risk of graft
migration.11 Additionally, the inability of many devices to
cope with severe neck angulation resulting in asymmetrical
device deployment may render the endograft more sus-
ceptible to migration.12 Consequently, neck angulation has
been associated with an increased risk of adverse
aneurysm-related events in the short and midterm.13Moreover, owing to these concerns, patients with severe
proximal anatomy were excluded from several major trials
and, consequently, outcomes in this particular subgroup
have not been easily assessable. In a EUROSTAR-based
report from Hobo et al. with a mean (SD) follow-up of
19.9 (17.9) months (n ¼ 1,152), patients with severe
proximal angulation were at increased risk of presenting a
proximal type 1 endoleak (HR 1.80, 95% CI 1.25e2.58).14
Recent devices have been specially designed to broaden
EVAR applicability particularly in more challenging proximal
neck anatomies. Weale et al. reported their prospective
experience with the use of the Aorﬁx (Lombard Medical,
Didcot, UK),15 a US Food and Drugs Administration-
approved device for the treatment of patients with AAA
with up to 90 angulated necks. In a group of 30 patients
with a mean infrarenal angle of 81.2 [range 63e110],
two (6.7%) cases of primary proximal type 1 endoleaks were
found to persist at the 6-month follow-up, despite intra-
operative ballooning of the proximal stent. The Anaconda
AAA stent graft system (Vascutek, Terumo, Inchinnan, UK)
has also claimed a role in the management of patients with
AAA with angulated proximal anatomy. Rödel et al. reported
recently on the 4-year outcomes of this device in a group of
36 patients with proximal neck angulation >60.16 Primary
clinical success had been sustained in 25 (69%) patients.
Two endograft occlusions were reported along with ﬁve
limb occlusions, particularly, according to the authors, in the
presence of increased neck angulation. Additionally, one
patient presented a migration of the device with proximal
type 1 endoleak. In a retrospective analysis of 519 patients
treated with the Endologix graft (Endologix, Irvine, CA,
USA), Qu et al. reported,17 in a subgroup of 36 patients with
neck angulation >60, one (2.8%) secondary proximal type
1 endoleak during an overall mean follow-up of 2.6 years
(range 4.0 months to 5.0 years). Nevertheless, 25 (69.0%) of
these patients had required additional proximal cuffs or
Palmaz stents during the primary intervention. In the
sample in the present study, only one (2.2%) patient in the
study group required an additional proximal extension
intraoperatively.4
26 N.F.G. Oliveira et al.Morphological neck changes and proximal device ﬁxation
of the Endurant Stent Graft were evaluated in the sample
presented herein. Barb detachment may result from the
inability of the barb to follow the lesser aortic curvature in
very angulated necks. In the current sample, patients with
severe neck angulation presented a 3.7-fold increased risk
of single barb detachment. However, multiple barb
detachment was not identiﬁed and barb detachment did
not increase over time. Moreover, this ﬁnding does not
represent device failure as signiﬁcant migration was not
identiﬁed among the present population.
Increased device oversizing has been used to ensure
adequate proximal seal, particularly in situations prone to
eccentric deployment, such as in the presence of severe
proximal neck angulation, which was also identiﬁed among
the present study group. However, other morphologic fea-
tures also differentiated signiﬁcantly the study group: neck
length was shorter (p ¼ .05; Table 1), aneurysms were
larger (p < .01), and, as reported previously, patients in the
study group presented a greater variability in neck confor-
mation, assuming more frequently a noncylindrical form.4 It
is hypothesized that in patients with cylindrical proximal
aneurysm necks, increased oversizing may not be warranted
as unlike devices with columnar strength, the high con-
formability of the Endurant Stent Graft enables it to follow
intimately the aneurysm neck curvature in severely angu-
lated anatomy. EVAR has been found to induce dynamic
morphologic remodeling of the neck, as reported by van
Keulen et al.,17 particularly with the deployment of
endografts with columnar strength. Hoshina et al. found
that in a group of 46 patients with proximal neck angulation
>60,18 41 (89.0%) presented signiﬁcant and straightening
immediately after endograft deployment. Moreover, the
rate of further straightening during follow-up was graft-
dependent. Statistically signiﬁcant reductions were also
identiﬁed in both suprarenal and infrarenal neck angles,
which were more pronounced in the angulated group,
despite the high ﬂexibility of the device deployed. However,
when comparing suprarenal and infrarenal angle variation
on the last available CTA to the ﬁrst postoperative one, the
present data suggest that signiﬁcant angle reduction
occurred only immediately after device deployment and did
not modify, as the Endurant Stent Graft remained adapted
to the underlying anatomy. The authors hypothesize that
the increased ﬂexibility of this device, which leads to a more
concentric deployment of the endograft and enduring
conformation to an unstrained aortic neck in the mid-term,
may result in decreased morphologic neck modiﬁcation,
which, in turn, may contribute to a decreased risk of neck
dilatation, proximal type 1 endoleak, or device migration.
Noticeable limitations to the present study include its
retrospective design, which is subject to selection and
reporting bias, thus contributing to the signiﬁcantly
different mean follow-up time among groups. Nevertheless,
all patients were treated in a consecutive fashion with the
same endograft, followed prospectively, and life-table
analysis was performed showing no difference in any of
the endpoints. Additionally, case volume may limit thereproducibility of the ﬁndings at other centers. However, as
all patients received the same endograft, the conclusions
may be clinically relevant to many centers where this device
is currently available. Finally, the sample size may limit
revealing of more subtle differences between groups.
However, this report represents the largest study to date
reporting on clinical outcomes following EVAR in patients
with severe proximal neck angulation during a median
follow-up of 4 years.
CONCLUSION
EVAR with the Endurant Stent Graft System is safe in pa-
tients with severe proximal neck angulation provided that a
suitable proximal seal length is obtained. Mid-term
outcome and freedom from neck-related reinterventions
were not inﬂuenced by the severity of proximal neck
angulation. Aortic neck remodeling occurred more signiﬁ-
cantly in patients with adverse neck anatomy but angula-
tion changes were not marked and did not modify
signiﬁcantly during follow-up, conﬁrming the enduring
ability of this device to conform to challenging anatomies
over time.
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